Trials / Completed
CompletedNCT05047029
Myocardial Fibrosis and Inflammation in Liver Cirrhosis
Multiparametric Magnetic Resonance Imaging in Patients With Liver Cirrhosis for Evaluation of Myocardial Fibrosis and Inflammation in Cirrhotic Cardiomyopathy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (actual)
- Sponsor
- University Hospital, Bonn · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The aim of this clinical prospective study is to assess structural and functional myocardial changes in patients with liver cirrhosis after implantation of transjugular intrahepatic portosystemic shunt (TIPS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Transjugular intrahepatic portosystemic shunt implantation | Transjugular intrahepatic portosystemic shunt is an artificial channel within the liver that establishes communication between the inflow portal vein and the outflow hepatic vein. It is used to treat portal hypertension (e.g., in liver cirrhosis) |
| DIAGNOSTIC_TEST | Magnetic resonance imaging | Multiparametric cardiac and hepatic magnetic resonance imaging |
Timeline
- Start date
- 2018-11-02
- Primary completion
- 2021-01-05
- Completion
- 2021-09-08
- First posted
- 2021-09-16
- Last updated
- 2021-09-16
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT05047029. Inclusion in this directory is not an endorsement.